Sorrento Therapeutics, Inc.
SRNEDelisted Apr 12, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000850261
Sorrento Therapeutics, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 20, 2023; 224 institutions reported holding it in 13F filings for Q4 2022, worth $180.7M in total; Oaktree Capital was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 224
- Q4 2022, −6 vs. previous quarter
- 13F value
- $180.7M
- Reported value at the end of Q4 2022
- Superinvestors holding
- 1
- At the end of Q4 2022
Superinvestors holding SRNE, Q4 2022
1 superinvestor reports holding Sorrento Therapeutics, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Oaktree Capital
Howard Marks
<0.1%
Sorrento Therapeutics, Inc.'s share of the portfolio
- Shares
- 134,000
- Value
- $118.7K
Latest insider trades
Open-market purchases and sales by Sorrento Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2022 (view filing) | Sep 7 | Same day | Ji HenrySee Remarks | PPurchase | +88.9K | $2.02 | +$179.6K | +1.9%4.77M after | |
| Sep 7, 2022 (view filing) | Sep 7 | Same day | Ji HenrySee Remarks | PPurchase | +88.8K | $0.4081 | +$36.2K | –129 after | Derivative2 lots |
| Sep 6, 2022 (view filing) | Sep 6 | Same day | Ji HenrySee Remarks | PPurchase | +55.6K | $1.96 | +$108.9K | +1.2%4.68M after | |
| Aug 26, 2022 (view filing) | Aug 26 | Same day | Ji HenrySee Remarks | PPurchase | +33.3K | $2.11 | +$70.3K | +1.6%2.12M after | |
| Aug 26, 2022 (view filing) | Aug 26 | Same day | Ji HenrySee Remarks | SSale | −20.0K | $3.49 | −$69.9K | –200 after | Derivative |
| Aug 25, 2022 (view filing) | Aug 25 | Same day | Ji HenrySee Remarks | PPurchase | +22.2K | $2.06 | +$45.8K | +1.1%2.09M after | |
| Aug 25, 2022 (view filing) | Aug 25 | Same day | Ji HenrySee Remarks | PPurchase | +100.0K | $0.3066 | +$30.7K | –1.00K after | Derivative |
| Jun 14, 2022 (view filing) | Jun 14 | Same day | Ji HenrySee Remarks | PPurchase | +10.0K | $1.40 | +$14.0K | +0.5%2.07M after | |
| Dec 27, 2021 (view filing) | Dec 27 | Same day | Janda KimDirector | SSale | −3.00K | $5.88 | −$17.6K | −50.0%3.00K after | |
| Sep 28, 2021 (view filing) | Sep 27 | 1 day | Janda KimDirector | SSale | −42.4K | $8.02 | −$339.7K | −93.4%3.00K after |
Top 10 13F holders, Q4 2022
The largest institutional positions in Sorrento Therapeutics, Inc. at the end of Q4 2022; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 50,637,571 | $44.9M | 0.00% | +9,968,295+24.5% | Added |
| BlackRock Inc. | 39,423,641 | $34.9M | 0.00% | +5,244,074+15.3% | Added |
| Vanguard Group Inc | 29,535,954 | $26.2M | 0.00% | +7,019,380+31.2% | Added |
| Geode Capital Management, LLC | 8,905,936 | $7.89M | 0.00% | +1,797,652+25.3% | Added |
| B. Riley Financial, Inc. | 5,216,250 | $4.62M | 1.04% | +5,216,250 | New |
| B. Riley Securities, Inc. | 5,216,250 | $4.62M | 1.01% | +5,216,250 | New |
| D. E. Shaw & Co., Inc. | 5,106,072 | $4.52M | 0.01% | +49,109+1.0% | Added |
| Rafferty Asset Management, LLC | 4,394,415 | $3.89M | 0.03% | +1,399,741+46.7% | Added |
| Northern Trust Corp | 4,180,871 | $3.70M | 0.00% | +743,271+21.6% | Added |
| Charles Schwab Investment Management Inc | 3,508,377 | $3.11M | 0.00% | +674,716+23.8% | Added |